Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nerve Degeneration D009410 53 associated lipids
Nervous System Diseases D009422 37 associated lipids
Neuralgia D009437 28 associated lipids
Neuroblastoma D009447 66 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Neutropenia D009503 15 associated lipids
Osteonecrosis D010020 5 associated lipids
Pain D010146 64 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Pancreatitis D010195 10 associated lipids
Parkinson Disease D010300 53 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Peritonitis D010538 38 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Pleurisy D010998 20 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Polycythemia Vera D011087 13 associated lipids
Pregnancy Complications, Cardiovascular D011249 11 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Proteinuria D011507 30 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Psoriasis D011565 47 associated lipids
Pulmonary Edema D011654 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Rhinitis D012220 10 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Osteosarcoma D012516 50 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Seizures D012640 87 associated lipids
Shock D012769 11 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Shock, Septic D012772 11 associated lipids
Shock, Traumatic D012774 4 associated lipids
Sneezing D012912 6 associated lipids
Spasm D013035 5 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Stomach Ulcer D013276 75 associated lipids
Stomatitis D013280 14 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Tangier Disease D013631 8 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Jeewandara C et al. Platelet activating factor contributes to vascular leak in acute dengue infection. 2015 PLoS Negl Trop Dis pmid:25646838
Valli A et al. Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways. 2015 Oncotarget pmid:25605240
Yamaguchi M et al. A platelet-activating factor (PAF) receptor deficiency exacerbates diet-induced obesity but PAF/PAF receptor signaling does not contribute to the development of obesity-induced chronic inflammation. 2015 Biochem. Pharmacol. pmid:25577975
Johnson M et al. Levocetirizine and rupatadine in chronic idiopathic urticaria. 2015 Int. J. Dermatol. pmid:25521304
Kim H et al. Higher plasma platelet-activating factor levels are associated with increased risk of vertebral fracture and lower bone mineral density in postmenopausal women. 2015 J. Bone Miner. Metab. pmid:25501698
Ohshima N et al. New members of the mammalian glycerophosphodiester phosphodiesterase family: GDE4 and GDE7 produce lysophosphatidic acid by lysophospholipase D activity. 2015 J. Biol. Chem. pmid:25528375
Pałgan K and Bartuzi Z Platelet activating factor in allergies. 2015 Int J Immunopathol Pharmacol pmid:26486136
Hergott CB et al. Bacterial exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway infection. 2015 J. Clin. Invest. pmid:26426079
Speciani AF and Piuri G Measuring Biomarkers for an Innovative Personal Food Profile. 2015 J Am Coll Nutr pmid:26400432
Pei HX et al. Ginkgolide B Reduces the Degradation of Membrane Phospholipids to Prevent Ischemia/Reperfusion Myocardial Injury in Rats. 2015 Pharmacology pmid:26382046
Tiniakou I et al. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice. 2015 Atherosclerosis pmid:26363436
Vlachogianni IC et al. Platelet Activating Factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions. 2015 Prostaglandins Other Lipid Mediat. pmid:26358846
Jiao D et al. Macrophages are the dominant effector cells responsible for IgG-mediated passive systemic anaphylaxis challenged by natural protein antigen in BALB/c and C57BL/6 mice. 2014 May-Jun Cell. Immunol. pmid:24751884
Yamauchi A et al. Systematic single cell analysis of migration and morphological changes of human neutrophils over stimulus concentration gradients. 2014 J. Immunol. Methods pmid:24370750
Flasiński M et al. Influence of platelet-activating factor, lyso-platelet-activating factor and edelfosine on Langmuir monolayers imitating plasma membranes of cell lines differing in susceptibility to anti-cancer treatment: the effect of plasmalogen level. 2014 J R Soc Interface pmid:24694892
Sato A et al. C-reactive protein specifically enhances platelet-activating factor-induced inflammatory activity in vivo. 2014 Eur. J. Pharmacol. pmid:25455842
Zebrowska A et al. Mediators of mast cells in bullous pemphigoid and dermatitis herpetiformis. 2014 Mediators Inflamm. pmid:25400334
Sahu RP et al. Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor. 2014 Cancer Res. pmid:25304264
Yu Y et al. Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells. 2014 J. Exp. Clin. Cancer Res. pmid:25261977
Agrawal V et al. Platelet-activating factor: a role in preterm delivery and an essential interaction with Toll-like receptor signaling in mice. 2014 Biol. Reprod. pmid:25253732
Wang M et al. Mouse anaphylactic shock is caused by reduced cardiac output, but not by systemic vasodilatation or pulmonary vasoconstriction, via PAF and histamine. 2014 Life Sci. pmid:25252221
Liu X et al. Ginkgolide B inhibits platelet release by blocking Syk and p38 MAPK phosphorylation in thrombin-stimulated platelets. 2014 Thromb. Res. pmid:25223809
Kang LP et al. Steroidal saponins from Tribulus terrestris. 2014 Phytochemistry pmid:25172515
Wu KZ et al. Establishment of the method for screening the potential targets and effective components of huatuo reconstruction pill. 2014 Interdiscip Sci pmid:25172450
Nitoda E et al. Correlation of platelet activating factor and age-related macular degeneration. 2014 Expert Opin. Ther. Targets pmid:25077601
Sirangelo I et al. Platelet-activating factor mediates the cytotoxicity induced by W7FW14F apomyoglobin amyloid aggregates in neuroblastoma cells. 2014 J. Cell. Biochem. pmid:25053109
Xanthopoulou MN et al. Effect of Robola and Cabernet Sauvignon extracts on platelet activating factor enzymes activity on U937 cells. 2014 Food Chem pmid:25038648
Concha C et al. Oxidative response of neutrophils to platelet-activating factor is altered during acute ruminal acidosis induced by oligofructose in heifers. 2014 J. Vet. Sci. pmid:25013355
Wu H et al. Lipoxin A4 and platelet activating factor are involved in E. coli or LPS-induced lung inflammation in CFTR-deficient mice. 2014 PLoS ONE pmid:24671173
Carlioglu A et al. The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome. 2014 Arch. Gynecol. Obstet. pmid:24840107
Yu Y et al. Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells. 2014 J Ovarian Res pmid:24721622
Forkel S et al. Inositoylated platelet-activating factor (Ino-C2-PAF) modulates dynamic lymphocyte-endothelial cell interactions and alleviates psoriasis-like skin inflammation in two complementary mouse models. 2014 J. Invest. Dermatol. pmid:24714204
Kim SJ et al. Quantitative determination of major platelet activating factors from human plasma. 2014 Anal Bioanal Chem pmid:24682147
Kaplanis M et al. Re(I) tricarbonyl complex of 1,10-phenanthroline-5,6-dione: DNA binding, cytotoxicity, anti-inflammatory and anti-coagulant effects towards platelet activating factor. 2014 J. Inorg. Biochem. pmid:24632342
Mallet de Lima CD et al. Central role of PAFR signalling in ExoU-induced NF-κB activation. 2014 Cell. Microbiol. pmid:24612488
Moschos MM et al. In vitro effects of vitamin supplements on platelet-activating factor and its metabolism in age-related macular degeneration. 2014 Cutan Ocul Toxicol pmid:24147947
Abdulnour RE et al. Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25369934
Chou YI et al. Correlations of platelet-derived microparticles with thromboxane B2, platelet-activating factor, endothelin-1, and neutrophil to lymphocyte ratio in patients with coronary intermediate lesions. 2014 Biomarkers pmid:25391885
Chacón-Salinas R et al. An essential role for platelet-activating factor in activating mast cell migration following ultraviolet irradiation. 2014 J. Leukoc. Biol. pmid:24009177
Mehta A and Sigman M Identification and preparation of sperm for ART. 2014 Urol. Clin. North Am. pmid:24286775
Reyes-Quiroz ME et al. Platelet-activating factor downregulates the expression of liver X receptor-α and its target genes in human neutrophils. 2014 FEBS J. pmid:24289152
Semini G et al. Inositol-C2-PAF down-regulates components of the antigen presentation machinery in a 2D-model of epidermal inflammation. 2014 Biochem. Pharmacol. pmid:24291779
Chérifi F et al. Isolation, functional characterization and proteomic identification of CC2-PLA₂ from Cerastes cerastes venom: a basic platelet-aggregation-inhibiting factor. 2014 Protein J. pmid:24384926
Rivera J et al. Platelet-activating factor contributes to Bacillus anthracis lethal toxin-associated damage. 2014 J. Biol. Chem. pmid:24478317
Kim KJ et al. Platelet-activating factor enhances tumour metastasis via the reactive oxygen species-dependent protein kinase casein kinase 2-mediated nuclear factor-κB activation. 2014 Immunology pmid:24628121
Gazos-Lopes F et al. Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi. 2014 PLoS Negl Trop Dis pmid:25101628
Semini G et al. Glycosidated phospholipids - a promising group of anti-tumour lipids. 2014 Anticancer Agents Med Chem pmid:24628240
Morimoto R et al. Rapid production of platelet-activating factor is induced by protein kinase Cα-mediated phosphorylation of lysophosphatidylcholine acyltransferase 2 protein. 2014 J. Biol. Chem. pmid:24742674
Summers C et al. Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome. 2014 Thorax pmid:24706039
Yang Y et al. Basophil activation through ASGM1 stimulation triggers PAF release and anaphylaxis-like shock in mice. 2014 Eur. J. Immunol. pmid:24777913